Your browser doesn't support javascript.
loading
Statin withdrawal and treating COVID-19 patients.
Fedson, David S.
Affiliation
  • Fedson DS; Sergy Haut, France.
Pharmacol Res Perspect ; 9(6): e00861, 2021 12.
Article in En | MEDLINE | ID: mdl-34708573
Most but not all observational studies of statin treatment of COVID-19 patients suggest that treatment improves outcomes. However, almost all of these studies fail to consider that withdrawing statins after hospital admission may have detrimental effects, a finding which cardiovascular investigators have known for 15-20 years. Continuing or starting statin treatment after hospital admission consistently improves cardiovascular outcomes. Similarly, inpatient statin treatment of COVID-19 improves survival. For this reason, observational studies of the effectiveness of outpatient-documented statin treatment of COVID-19 patients must consider the negative consequences of statin withdrawal after hospital admission.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 Drug Treatment Type of study: Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: Pharmacol Res Perspect Year: 2021 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 Drug Treatment Type of study: Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: Pharmacol Res Perspect Year: 2021 Document type: Article Affiliation country: France Country of publication: United States